RC

Roshantha A. Chandraratna

AB AbbVie: 221 patents #1 of 1,308Top 1%
IT Io Therapeutics: 63 patents #1 of 19Top 6%
DC Dartmouth College: 8 patents #35 of 689Top 6%
JM Johns Hopkins University School Of Medicine: 4 patents #40 of 255Top 20%
The Johns Hopkins University: 2 patents #1,071 of 4,416Top 25%
JM John Hopkins University, School Of Medicine: 1 patents #7 of 55Top 15%
TT The University Of Texas: 1 patents #15 of 46Top 35%
CC City Of Hope National Medical Center: 1 patents #2 of 13Top 20%
📍 San Juan Capistrano, CA: #2 of 406 inventorsTop 1%
🗺 California: #245 of 386,348 inventorsTop 1%
Overall (All Time): #1,365 of 4,157,543Top 1%
294
Patents All Time

Issued Patents All Time

Showing 1–25 of 294 patents

Patent #TitleCo-InventorsDate
12383521 Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle, Martin E. Sanders 2025-08-12
11793781 Autoimmune disorder treatment using RXR agonists Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle 2023-10-24
11786555 RAR selective agonists in combination with immune modulators for cancer immunotherapy Martin E. Sanders 2023-10-17
11779558 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Martin E. Sanders 2023-10-10
11737996 Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Martin E. Sanders 2023-08-29
11690832 Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones Martin E. Sanders 2023-07-04
11690831 Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones Martin E. Sanders 2023-07-04
11648223 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Martin E. Sanders 2023-05-16
11648222 Use of CYP26-resistant RAR alpha selective agonists in the treatment of cancer Gabriel Ghiaur, Richard J. Jones, Salvador Alonso 2023-05-16
11576881 Autoimmune disorder treatment using RXR agonists Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle 2023-02-14
11547684 Autoimmune disorder treatment using RXR agonists Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle 2023-01-10
11517549 Treatment of disease with esters of selective RXR agonists Martin E. Sanders 2022-12-06
11246845 Autoimmune disorder treatment using RXR agonists Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle 2022-02-15
11166927 Autoimmune disorder treatment using RXR agonists Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle 2021-11-09
11065219 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-07-20
10987330 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-04-27
10980760 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-04-20
10980759 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-04-20
10980761 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-04-20
10973791 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-04-13
10973788 Treatment of cancer with specific RXR agonists 2021-04-13
10946001 Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones Martin E. Sanders 2021-03-16
10945976 Autoimmune disorder treatment using RXR agonists Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle 2021-03-16
10940127 Use of CYP26-resistant RAR alpha selective agonists in the treatment of cancer Gabriel Ghiaur, Richard J. Jones, Alonso Salvador 2021-03-09
10919835 Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids Vidyasagar Vuligonda, Thomas Jacks, Peter C. Wade, Andrew Thompson 2021-02-16